But beneath the surface of this public scrutiny lies the biggest threat to the traditional PBM structure, one that signals a quiet shift in the market: changing demands from employers, unions ...

Opinions expressed by Forbes Contributors are their own. I write about business model strategy and execution across healthcare. On the heels of the FTC’s investigation into pharmacy benefit ...

An FTC official told reporters the $7.3 billion figure could be an underestimation. PBM-affiliated pharmacy dispensing revenue increased at an annual growth rate of 42% from 2017 to 2021 ...